Examples of using Hypercalcaemia in English and their translations into Norwegian
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Hypo- or hypercalcaemia.
Treatment of Tumour-Induced Hypercalcaemia.
Reduction of hypercalcaemia in patients with.
Dose: Treatment of tumour-induced hypercalcaemia.
Uncommon: Hypercalcaemia.
Dosage: Treatment of Tumour-induced hypercalcaemia.
Hypercalcaemia was reported in clinical trials with Natpar.
Pre-existing hypercalcaemia.
Clinical studies in the treatment of tumour-induced hypercalcaemia.
Treatment of tumour-induced hypercalcaemia with or without metastases.
Patients with CKD may develop hypocalcaemia or hypercalcaemia.
Hypercalcaemia, hyperglycaemia, worsening of diabetic metabolic state.
This condition is known as tumour-induced hypercalcaemia TIH.
Hypo- or hypercalcaemia has been reported during capecitabine treatment.
Treatment of adult patients with tumour-induced hypercalcaemia TIH.
Hypercalcaemia of any cause may predispose to digitalis toxicity.
Rasitrio should be discontinued if hypercalcaemia develops during treatment.
Hypo- or hypercalcaemia has been reported during capecitabine treatment.
Copalia HCT should be discontinued if hypercalcaemia develops during treatment.
Untreated hypercalcaemia patients generally have some degree of renal function impairment, therefore careful renal function monitoring should be considered.
Refractory hypokalaemia, hyponatraemia, hypercalcaemia, and symptomatic hyperuricaemia. Severe hypotension.
The proportion of patients with at least one SRE(excluding hypercalcaemia) was 29.8% in the zoledronic acid-treated group versus 49.6% in the placebo group p=0.003.
Calcium, vitamin D, or Natpar doses may need to be reduced if post-dose hypercalcaemia is observed, even if pre-dose calcium concentrations are acceptable(see section 4.2).
Go hypercalcemia with underlying MEN syndrome!
Hypercalcemia as a result of IV administration of CaEDTA has been reported(5).
It may cause hypercalcemia in immobile patients.
Moderate to severe hypercalcemia(³ 2.9 mmol/l).
Other factors are dehydration, hypercalcemia, elevated uric acid, infections, and nephrotoxic medications.
The good news for you, though,is that you have a case of hypercalcemia.
Females with breast cancer and/or hypercalcemia.